Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial

被引:52
作者
Wernicke, A. Gabriella [1 ,2 ]
Hirschfeld, Cole B. [5 ]
Smith, Andrew W. [6 ]
Taube, Shoshana [1 ]
Yondorf, Menachem Z. [1 ]
Parashar, Bhupesh [1 ]
Nedialkova, Lucy [1 ]
Kulidzhanov, Fridon [1 ]
Trichter, Samuel [1 ]
Sabbas, Albert [1 ]
Ramakrishna, Rohan [2 ]
Pannullo, Susan [2 ]
Schwartz, Theodore H. [2 ,3 ,4 ]
机构
[1] Weill Cornell Med Coll, NewYork Presbyterian Hosp, Stich Radiat Oncol, 525 E 68th St, New York, NY 10065 USA
[2] Weill Cornell Med Coll, NewYork Presbyterian Hosp, Brain & Spine Ctr, Dept Neurosurg, New York, NY 10065 USA
[3] Weill Cornell Med Coll, NewYork Presbyterian Hosp, Dept Otorhinolaryngol, New York, NY 10065 USA
[4] Weill Cornell Med Coll, NewYork Presbyterian Hosp, Dept Neurosci, New York, NY 10065 USA
[5] Weill Cornell Med Coll, New York, NY 10065 USA
[6] Univ Rochester, Sch Med & Dent, Rochester, NY USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 98卷 / 05期
基金
美国国家卫生研究院;
关键词
STEREOTACTIC RADIOSURGERY BOOST; QUALITY-OF-LIFE; RADIATION-THERAPY; CEREBRAL METASTASES; SURGICAL RESECTION; RANDOMIZED-TRIAL; SINGLE METASTASES; LOCAL-CONTROL; RADIOTHERAPY; I-125;
D O I
10.1016/j.ijrobp.2017.03.044
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Studies on adjuvant stereotactic radiosurgery to the cavity of resected brain metastases have suggested that larger tumors (>2.0 cm) have greater rates of recurrence and radionecrosis (RN). The present study assessed the effect of permanent low-dose Cs-131 brachytherapy on local control and RN in patients treated for large brain metastases. Methods and Materials: After institutional review board approval, 42 patients with 46 metastases >= 2.0 cm in preoperative diameter were accrued to a prospective trial from 2010 to 2015. Patients underwent surgical resection with intraoperative placement of stranded Cs-131 seeds as permanent volume implants in the resection cavity. The primary endpoint was local freedom from progression (FFP). Secondary endpoints included regional and distant FFP, overall survival (OS), and RN rate. Failures 5 to 20 mm from the cavity and dural-based failures were considered regional. A separate analysis was performed for metastases >3.0 cm. Results: Of the 46 metastases, 18 were >3.0 cm in diameter. The median follow-up periodwas 11.9 months (range 0.6-51.9). The metastases had a median preoperative diameter of 3.0 cm (range 2.0-6.8). The local FFP rate was 100% for all tumor sizes. Regional recurrence developed in 3 of 46 lesions (7%), for a 1-year regional FFP rate of 89% (for tumors>3.0 cm, the FFP rate was 80%, 95% confidence interval 54%-100%). Distant recurrences were found in 19 of 46 lesions (41%), for a 1-year distant FFP rate of 52%. The median OS was 15.1 months, with a 1-year OS rate of 58%. Lesion size was not significantly associated with any endpoint on univariate or multivariate analysis. Radioresistant histologic features resulted in worse survival (P=.036). No cases of RN developed. Conclusions: Intraoperative Cs-131 brachytherapy is a promising and effective therapy for large brain metastases requiring neurosurgical intervention, which can offer improved local control and lower rates of RN compared with stereotactic radiosurgery to the resection cavity. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:1059 / 1068
页数:10
相关论文
共 45 条
[1]   Hypofractionated Stereotactic Radiotherapy in Five Daily Fractions for Post-Operative Surgical Cavities in Brain Metastases Patients With and Without Prior Whole Brain Radiation [J].
Al-Omair, Ameen ;
Soliman, Hany ;
Xu, Wei ;
Karotki, Aliaksandr ;
Mainprize, Todd ;
Nicolas Phan ;
Das, Sunit ;
Keith, Julia ;
Yeung, Robert ;
Perry, James ;
Tsao, May ;
Sahgal, Arjun .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2013, 12 (06) :493-499
[2]   Tumor bed radiosurgery: an emerging treatment for brain metastases [J].
Amsbaugh, Mark J. ;
Boling, Warren ;
Woo, Shiao .
JOURNAL OF NEURO-ONCOLOGY, 2015, 123 (02) :197-203
[3]   Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].
Andrews, DW ;
Scott, CB ;
Sperduto, PW ;
Flanders, AE ;
Gaspar, LE ;
Schell, MC ;
Werner-Wasik, M ;
Demas, W ;
Ryu, J ;
Bahary, JP ;
Souhami, L ;
Rotman, M ;
Mehta, MP ;
Curran, WJ .
LANCET, 2004, 363 (9422) :1665-1672
[4]  
[Anonymous], 2015, CANC FACTS FIG 2015
[5]   Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases - A randomized controlled trial [J].
Aoyama, Hidefumi ;
Shirato, Hiroki ;
Tago, Masao ;
Nakagawa, Keiichi ;
Toyoda, Tatsuya ;
Hatano, Kazuo ;
Kenjyo, Masahiro ;
Oya, Natsuo ;
Hirota, Saeko ;
Shioura, Hiroki ;
Kunieda, Etsuo ;
Inomata, Taisuke ;
Hayakawa, Kazushige ;
Katoh, Norio ;
Kobashi, Gen .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2483-2491
[6]   INTERSTITIAL BRACHYTHERAPY FOR MALIGNANT BRAIN-TUMORS - PRELIMINARY-RESULTS [J].
BERNSTEIN, M ;
LAPERRIERE, N ;
LEUNG, P ;
MCKENZIE, S .
NEUROSURGERY, 1990, 26 (03) :371-380
[7]   Resection and permanent I-125 brachytherapy without whole brain irradiation for solitary brain metastasis from non-small cell lung carcinoma [J].
Bogart, JA ;
Ungureanu, C ;
Shihadeh, E ;
Chung, CT ;
King, GA ;
Ryu, S ;
Kent, C ;
Winfield, JA .
JOURNAL OF NEURO-ONCOLOGY, 1999, 44 (01) :53-57
[8]   A Phase 2 Trial of Stereotactic Radiosurgery Boost After Surgical Resection for Brain Metastases [J].
Brennan, Cameron ;
Yang, T. Jonathan ;
Hilden, Patrick ;
Zhang, Zhigang ;
Chan, Kelvin ;
Yamada, Yoshiya ;
Chan, Timothy A. ;
Lymberis, Stella C. ;
Narayana, Ashwatha ;
Tabar, Viviane ;
Gutin, Philip H. ;
Ballangrud, Ase ;
Lis, Eric ;
Beal, Kathryn .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (01) :130-136
[9]   Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial [J].
Chang, Eric L. ;
Wefel, Jeffrey S. ;
Hess, Kenneth R. ;
Allen, Pamela K. ;
Lang, Frederick F. ;
Kornguth, David G. ;
Arbuckle, Rebecca B. ;
Swint, J. Michael ;
Shiu, Almon S. ;
Maor, Moshe H. ;
Meyers, Christina A. .
LANCET ONCOLOGY, 2009, 10 (11) :1037-1044
[10]   The Correlation between Apparent Diffusion Coefficient and Tumor Cellularity in Patients: A Meta-Analysis [J].
Chen, Lihua ;
Liu, Min ;
Bao, Jing ;
Xia, Yunbao ;
Zhang, Jiuquan ;
Zhang, Lin ;
Huang, Xuequan ;
Wang, Jian .
PLOS ONE, 2013, 8 (11)